| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action antagonists | 
| Mechanism A3R antagonists(Adenosine A3 receptor antagonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Colonic Cancer | Preclinical | South Korea  | 01 Nov 2024 | |
| Liver Cancer | Preclinical | South Korea  | 01 Nov 2024 | 





